https://www.avient.com/sites/default/files/2021-12/Chemically Resistant Materials Whitepaper.pdf
Images of A) Trilliant HC8900 series,
B) FR PC alloys, and C) FR copolyester tensile bars in the strain apparatus following a
72-hour treatment with Virex® TB.
R.; Richards, C.
C.; Gaynes, R.
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
Polymer Diagnostics Inc.
PDI has extensive experience with
the testing of medical devices and
materials including:
• Catheters
• Bio-implants
• Surgical diagnostic devices
• Medical tubing
• Other disposable medical devices
Issues often arise as a result of:
• Improper design or choice of material
• The environment of exposure
• Processing conditions
World-class people and capabilities
under one roof
• Failure Analysis/Prevention
• Qualifi cation Support
• Rheology
• Polymer Characterization
• Deformulation
• Physical Testing
• Litigation Support
• Characterization of polymers in pharmaceutical
delivery systems
• Phthalate and BPA testing
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
Polymer Diagnostics Inc.
C M Y K HC_Industry bulletin_PDI_fi nal.indd REMAY 78810
TR: 16.5000" x 11.6875" and 17.000" x 11.000" Digital/IAM
BL: 17.2500" x 11.9375"
FINAL: 8.2500" x 11.6875" and 8.500" x 11.000"
i n
https://www.avient.com/sites/default/files/2023-03/AVNT Q2 2022 Earnings Presentation - Website Version.pdf
Microsoft PowerPoint - AVNT Q2 2022 Earnings Presentation
AVIENT CORPORATION
S E C O N D Q U A R T E R 2 0 2 2 R E S U L T S
(NYSE: AVNT)
J U LY 2 6 , 2 0 2 2
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Annual Purchases
RAW MATERIAL AND SUPPLY CHAIN UPDATE
Based on 2021 purchases, excludes Distribution business
SEGMENT DATA
U.S. & Canada
50%
Latin America
2021 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
19%
Building and
END MARKET REVENUE
(1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs
$2,402M
$409M
$919M
$164M
$1,631M
$94M
Sales EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$581M$4,819M
(1)
24
34%
Building &
1% Telecommunications
C O L O R , A D D I T I V E S & I N K S
2021 REVENUE | $2 .4 BILL ION
32%
40%
Latin America
END MARKET REGION
25
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
27%
Building &
2021 REVENUE | $919 MILLION
END MARKET
55%
REGION
26
D I S T R I BU T I O N
26%
Building and
80%
3%
Latin
America
END MARKET REGION
K E Y S U P P L I ER S
2021 REVENUE | $1 .6 B ILL ION
27
TOTA L C O M PA N Y R E G I O N A L S A L E S
BY END MARKET
30%
26%Healthcare
14%
Building &
2% Energy
(16% of sales)
32%
Building &
(25% of sales)
28
19%
Building &
US &
Canada
(50% of sales)
38%
33%
Building &
LATAM
(9% of sales)
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2022-09/PREPERM for 5G Application Bulletin %281%29.pdf
• Stable and controlled dielectric constant
- from 2.6 to 23
• Very low losses even at mmWaves
• Isotropic material - no glass fibers
• Can be injection molded and machined
APPLICATION BULLETIN
STABLE RF PROPERTIES OVER A WIDE FREQUENCY RANGE
0,0
2,0
4,0
6,0
8,0
10,0
12,0
D
ie
le
ct
ri
c
PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0
PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0
PR E PE RM® PPE 26 0
LOW LOSSES UP TO mmWAVE FREQUENCIES*
BATCH-TO-BATCH STABILITY DURING PRODUCTION
* Measurements performed at VTT Technical Research
Centre of Finland Ltd in 2018.
Di
el
ec
tr
ic
co
ta
Di
el
ec
tr
ic
co
Frequency [GHz]
Frequency [GHz]
Pallet number (1250 kg/pallet)
PREPERM™ PPE950
PREPERM™ PPE800
PREPERM™ PPE440
PREPERM™ PPE320
PREPERM™ PPE260
-- Dielectric constant target
-- +/- 2%
3,76
3,78
3,80
3,82
3,84
3,86
3,88
3,90
3,92
3,94
0 1 2 3 4 5 6 7 8
D
ie
le
ct
ri
c
P a llet number (1250 k g/pa llet )
Die le ctric cons ta nt ta rge t +/- 2 %
t
PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0
PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0
PR E PE RM® PPE 26 0
t
PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0
PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0
PR E PE RM® PPE 26 0
t
PR E PE RM® PPE 95 0 PR E PE RM® PPE 80 0
PR E PE RM® PPE 44 0 PR E PE RM® PPE 32 0
PR E PE RM® PPE 26 0
Copyright © 2022, Avient Corporation.
https://www.avient.com/sites/default/files/2020-08/stan-tone-epx-product-bulletin.pdf
% Pigment Specific Gravity Color Index Lightfastness
WHITE
10EPX03 Titanium Dioxide, Rutile 57 1.95 PW-6 I/O
YELLOW
12EPX01 Diarylide AAOT GS 25 1.22 PY-14 I
12EPX03 Diarylide HR RS 20 1.2 PY-83 I/O (Mass)
13EPX02 Isoindolinone RS 30 1.3 PY-110 I/O
13EPX03 Benzimidazolone GS 40 1.27 PY-151 I/O (Mass)
81EPX01 Iron Oxide 40 1.62 PY-42 I/O
ORANGE
15EPX03 Benzimidazolone 30 1.26 PO-36 I/O
RED
23EPX04 Quinacridone BS 25 1.21 PV-19 I/O
23EPX06 Specialty Naphthol BS 30 1.21 PR-170 I/O (Mass) C
25EPX01 Red 2B, Ca Salt Bs 24 1.27 PR-48:2 I/O (Mass)
28EPX01 Red 2B, Ba Salt YS 23 1.29 PR-48:1 I/O (Mass)
82EPX01 Iron Oxide, Light BS 40 1.67 PR-101 I/O
82EPX02 Iron Oxide, Dark BVS 40 1.68 PR-101 I/O
82EPX04 Iron Oxide, Light VYS 40 1.67 PR-101 I/O
BLUE
40EXP03 Phthalocyanine GS 25 1.25 PB-15:3 I/O
40EXP05 Phthalocyanine RS 25 1.25 PB-15:3 I/O
42EXP02 Ultramarine 50 1.54 PB-29 I/O
49EXP01 Cobalt 50 1.83 PB-28 I/O
GREEN
50EPX02 Phthalocyanine BS 18 1.34 PG-7 I/O
50EPX03 Phthalocyanine YS 25 1.42 PG-7 I/O
59EPX01 Chromium Oxide 40 1.64 PG-17 I/O
VIOLET/MAGENTA
24EPX03 Quinacridone Violet 15 1.2 PV-19 I/O
24EPX04 Ultramarine Violet 50 1.66 PV-15 I/O
24EPX05 Quinacridone Magenta 20 1.21 PR-122 I/O
24EPX06 Benzimidazolone 20 1.2 PV-32 I/O
24EPX07 Carbazole Violet 15 1.2 PV-23 I/O
BROWN/TAN
83EPX01 Iron Oxide, Light 39 1.64 PBr-6 I/O
83EPX02 Iron Oxide, Dark 40 1.66 PBr-6 I/O
BLACK
90EPX01 Furnace - High Jet 14 1.23 PBk-7 I/O
90EPX04 Furnace - Medium 20 1.25 PBk-7 I/O
90EPX05 Iron Oxide 50 1.77 PBk-11 I/O
EPX
RS = Red Shade
YS = Yellow Shade
VYS = Very Yellow Shade
BS = Blue Shade
VBS = Very Blue Shade
GS = Green Shade
HR = Heat-Resistant
LIGHTFASTNESS
I = Indoor Only
I/O = Indoor or Outdoor
Mass = Outdoor Masstone
Application Only
C = Some Caution Advised
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Antimony Trioxide.pdf
CATEGORY DETAIL
EC Number 215-175-0
CAS Number 1309-64-4
Name Subclass 1 Antimony Trioxide (ATO)
Structural Formula
CHEMICAL IDENTITY
PROPERTY DETAIL
Physical State Solid
Form Powder
Color White
Odor Odorless
Melting Point 656°C
Boiling Point 1425°C
Bulk Density 5.20 g/cm3
Water Solubility Slightly Soluble
PHYSICAL/
CHEMICAL
PROPERTIES
HEALTH EFFECTS
HUMAN HEALTH SAFETY ASSESSMENT
Consumer
It is very unlikely that consumers would be exposed to ATO in its concentrated
form because it is only sold for industrial use to make polymers and other products
and is not sold directly to consumers.
https://www.avient.com/sites/default/files/2021-04/avient-colorants-germany-gmbh-cr-extract-30-april-2021.pdf
Seite 1 von 7
1 a)
Clariant Zweite Chemie GmbH
Frankfurt am Main
Am Unisyspark 1, 65843 Sulzbach
(Taunus)
c)
Erwerb und die Verwaltung von
Beteiligungen an Gesellschaften,
insbesondere solchen aus dem Bereich der
chemischen Industrie.
25.000,00
EUR
Ist nur ein Geschäftsführer bestellt, so vertritt er
die Gesellschaft allein.
Ott, Ulrich, Leonberg, *28.09.1956
20.09.2016
Fall 3
4 a)
Performance Masterbatches Germany
GmbH
Geändert, nun:
Brüningstraße 50, 65929 Frankfurt am Main
c)
Entwicklung, Herstellung, Verarbeitung und
der Vertrieb von chemischen Produkten
und verwandten Erzeugnissen und
Präparationen einschließlich
diesbezüglicher Forschung und
Entwicklung.
https://www.avient.com/sites/default/files/2022-11/Seat Buckle System Application Snapshot.pdf
TIER 1 SUPPLIER
S E A T B U C K L E S Y S T E M
• Rapid development of 3 colors for global OEM platform, for
3 materials (POM, SAN, PP)
• Help Tier 1 transition from printing to laser marking of
buckles
• Develop formulation that offers laser marking solution plus
color
• Quick reaction to develop three colors for
this global vehicle launch
• Smartbatch™ color + laser marking
formulation met requirements for critical
safety components
Smartbatch™ Combination Colorants &
Additives
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-12/case-study-versaflex-ce-antimicrobial-phone-case-1.pdf
PHONE CASE
BRAND
P H O N E C A S E S
• Compatible with antimicrobial additives
• Good stain resistance
• Non-yellowing
• Delivered enhanced solution that included
antimicrobial properties and stain resistance
• Collaborated with OEM and the foremost
supplier of antimicrobials to comply with key
bacterial growth requirements
Versaflex™ CE 3320-80 TPE
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-10/2024 AVNT Q3 Webcast Slides w appendix and non-GAAP.pdf
Microsoft PowerPoint - AVNT Q3 2024 Earnings Presentation_10.29_12PM
AVIENT CORPORATION
T H I R D Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4
F I N A N C I A L G U I D A N C E
(NYSE: AVNT)
O C T O B E R 3 1 , 2 0 2 4
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.